Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
University of Washington